Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance of Kadcyla in Breast Cancer

NCT02305641 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02305641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02305641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance of Kadcyla in Breast Cancer
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
May 21, 2015
Completion date
August 10, 2021
Enrollment
563 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer